Tim Fitzpatrick’s Post

The investigation into the dialysis center duopoly sheds light on the dominance that two key players hold, controlling 70-75% of the market share. Scrutinized in the past for limiting competition and increasing costs, the findings could pave the way for increased transparency and a more competitive landscape, benefiting those who rely on these essential services -patients. It will be interesting to see how the findings may influence future regulations and market dynamics. This investigation, with the ultimate goal of improving patient outcomes and reducing costs in mind, could also highlight the disparity between in-center and at-home dialysis treatment models. Addressing this imbalance may lead to more equitable access and a shifted focus of pursuing the home dialysis option at the very beginning of treatment plan development. #ckd #eskd #dialysis #homedialysis #patientrights #patientadvocacy #patientcenteredcare #valuebasedcare

Those familiar with the self-funded Healthplan sector understand the challenges posed by monopolies in the dialysis space. Cost-shifting to employer plans and misaligned care incentives are common issues. The recent antitrust probe into dialysis giants sheds light on these concerns. As someone navigating this domain with family members, witnessing firsthand the questionable tactics employed by providers hits close to home. While skeptical about the probe's potential impact on the powerful lobby, it's clear that reform is overdue in this critical sector. Read more about the ongoing antitrust probe in the dialysis industry: https://lnkd.in/dkU5Keg3 #Healthcare #Antitrust #Dialysis #IndustryInsights

When it comes to patient education, especially vis-à-vis chronic healthcare conditions like chronic kidney disease (CKD), you need to have some kind of structure to your education programs. Patients need manageable segments to avoid feeling overwhelmed in their diagnosis for CKD treatment and that's where Interwell Health comes in. When practitioners work in lock step with care team members like renal care coordinators to support patients, it is integral to delivering a values-based comprehensive care model. Interwell Health helps patients with critical care navigation and the safety net they need to be educated about how to best navigate their care journeys. Early education and intervention + the right care team with a patient POC like renal care coordinators= the right patient-centered care we need to mitigate disease and rising healthcare costs! #chronickidneydisease #nephrology #patienteducation #healthcare

1 out of 3 nephrology patients lack understanding of their condition and treatment options. Yet proper CKD #patienteducation delivers powerful results: ✅ Delays or prevents dialysis ✅ Reduces hospitalizations ✅ Improves quality of life ✅ Saves millions in healthcare costs — just a 1% reduction in the incidence of patients progressing to dialysis can save a health plan $52M in dialysis initiation costs alone. The key? A team-based approach where nephrologists and care team members work together to educate and support patients through their CKD journey. Read our blog on the importance of CKD patient education and tools available to support providers: https://lnkd.in/dztr4Ept

I know that speaking about anything other than home hemodialysis is frowned upon. I get it. We went from in-center hemodialysis to home hemodialysis. I am supposed to say, “Well, the good news is the patients are at home.” I can’t take that stance. All home modalities aren’t equal. There is residual renal function, urine output, mortality, and, most importantly, quality of life to factor into the equation. We want to discuss the ease of pulling a heavy machine through the airport on wheels and the ease of checking unlimited medical supplies with a doctor's note at no charge. That’s because one modality has our feed filled with promotion from patient advocates, while peritoneal dialysis doesn’t have a single player in the game. Our patient sent us this photo of them bringing four dialysate bags in their carry-on and borrowing a bellhop to hang a bag to do their one CAPD exchange without a cycler for their weekend trip. If you had a choice of one single dose exchange (QLPD) that had a 10-minute gravity fill followed by a 10-minute gravity drain daily without a cycler with diuretic support OR four times a week with 15G needles (but only 2 hours running and 45 minutes setup and clotting) What would you choose? You would choose what your clinical team wanted to discuss with you.

Here’s what I think nephrologists don’t understand about value based care. Everything here forward is speaking primarily about all other contract arrangements except for CKCC (traditional Medicare A&B innovation model) as that approach is still primarily negotiated with nephrologists/nephrology practices. ❗️It’s happening with or without you.❗️ When a care management company wins a contract with a payor, those members (patients) are purchased like a box of chocolates. The care management company never knows (fully) what they’re going to get. When they find out what they got (claims review, data analytics, risk assessment/stratification), they are looking for key relationships to help them better manage their portion of patients to try and widen the margin between expenses and savings. So when you receive a pitch deck and it has all this data on your patient population but you’ve never signed a contract, that’s because those patients are no longer only yours. They are now intertwined with another entity that is extending resources on behalf of the payor in the name of potential cost savings (and hopefully improvement in quality of care for the patient). Remember when medicine was primarily a relationship between a physician and a patient? Gone are those days. One day we’ll wake up and what we see in dialysis consolidation will exist in primary nephrology care.

Paid Online Focus Group on Dialysis Patients ($1500) For latest paid studies visit: https://lnkd.in/dacww5y2 . . #fgfinder #focusgroup #focusgroups #findfocusgroups #paidfocusgroups #onlinefocusgroups #findfocusgroup #paidfocusgroup #onlinefocusgroup #researchstudies #paidstudies #paidsurveys #researchstudy #marketresearch #payresearch #paidresearch

The Power of Continuous Improvement: Why Quality Matters in Dialysis Treatment at 7Med India Pvt. Ltd. At 7MED, we're committed to exceeding expectations in the medical technology space. As a marketer here, I'm often focused on getting the word out about our innovative dialysis solutions. But there's something even more fundamental that drives us: a relentless pursuit of continuous quality improvement . Better Patient Outcomes: By constantly evaluating and refining our dialysis machines and processes, we can optimize treatment efficacy and minimize complications. This translates to a better quality of life for patients. Enhanced Efficiency: It helps us identify areas for improvement in treatment delivery, leading to more streamlined workflows for healthcare providers. This translates to better time management and cost-effectiveness. Staying Ahead of the Curve: The medical field is constantly evolving. Continuous quality improvement allows us to stay at the forefront of advancements, ensuring our dialysis solutions are always up-to-date and effective. At 7MED, we believe that quality is non-negotiable. That's why continuous quality improvement is embedded in our company culture. We're proud to be part of an organization that prioritizes patient well-being above all else. www.7medindia.com Vikas Verma khushboo joshi #dialysis #healthcare #medicaltechnology #CQI #7MED #DialysisCare #HealthcareHeroes #KidneyHealth #KidneyAwareness #KidneyCare #7MedIndia #HealthForAll #AwarenessCampaign #MedicalExcellence #SupportPatients #EmpoweringHealth #CommunityHealth #PublicHealth #WellnessJourney #RaiseAwareness #HealthAwareness #StayHealthy #HealthyLifestyle

We Need to Talk About Renal Care  I’m posting this because enough is enough. The renal care industry is in crisis, and patients—vulnerable, struggling dialysis patients—are being preyed upon by corporations like NxStage Medical, Inc. Their actions are more than unethical; they are exploitative, manipulative, and blatantly disregard regulations designed to protect the very people they claim to serve. This is a public indictment of these predatory practices, and I am calling on my network to stand up for what’s right. Here’s the situation: NxStage uses Jimmie and Dawn Bates, two corporate-sponsored individuals, to masquerade as “Patient Advocates.” This branding stunt is an insult to real patient advocacy. These are not independent voices—they are paid ambassadors whose glossy campaigns drown out authentic advocates fighting for real progress in renal care. Why does this matter? Because this unchecked greed and manipulation hurt everyone: 🎯 Why This Letter Matters 🔎 Patient Trust Eroded – Patients deserve honesty, not lies. 🚫 FTC Rules Ignored – Corporate deception runs rampant. 🔇 Advocacy Space Corrupted – Real voices are silenced. ⚙️ Innovation Stalled – Profit > patient needs. 💔 Exploitation of Vulnerability – Dialysis patients deserve better. 📉 Systemic Progress Blocked – Outdated care models persist. 👮 Regulatory Bodies Complicit – Inaction enables abuse. ⚠️ Renal Patients Harmed – The ultimate cost is human. This isn’t just about one company; it’s about demanding integrity from a system that touches the lives of millions. The people responsible for this exploitation must be held accountable—there need to be real repercussions to send a message to the entire industry. I’m asking my network to do three things: 1️⃣ Share this issue to bring awareness. 2️⃣ Support organizations pushing for ethical reforms in renal care. 3️⃣ Demand action from the FTC, HHS, and CMS to crack down on predatory practices. #Dialysis patients deserve better. Renal care needs transparency. Fresenius Medical Care and #NxStage stop with the predatory behaviors Jean Moody-Williams Vern Buchanan Xavier Becerra Andy Pate Joe Turk Kara Massingham, MBA Nicholas Castellano

Practical approach to promote PD therapy 👍